EC approves Immuno-Oncology Combination, Bristol-Myers Squibbs Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen, for...
Opdivo + Yervoy Regimen now approved for unresectable or metastatic melanoma patients, regardless...
Merck Expands Popular Line of Guava® Flow Cytometers
Optical configurations meet needs of any lab, research discipline or individual application Product can...
Johnson & Johnson opens first international JLABs site in Canada
Johnson & Johnson Innovation LLC announced the opening of JLABS @ Toronto, a new 40,000-square-foot...
Pfizer awards more than $1 million to fund metastatic breast cancer research
Pfizer Inc announced that it has awarded a total of more than $1 million in...
Johnson & Johnson opens first international JLABs site in Canada
Johnson & Johnson Innovation LLC announced the opening of JLABS @ Toronto, a new 40,000-square-foot...
Merck Showcases New Innovations at Analytica 2016
Merck, a leading science and technology company, will exhibit a new range of products and...
Baxter to Present at the 2016 UBS Global Healthcare Conference
Baxter International Inc will present at the 2016 UBS Global Healthcare Conference on Monday, May...
Allergan and Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10...
Phase III study met all co-primary and secondary endpoints and achieved statistically significant resultsWorld pharma...
Merck Launches First Commercially Available Equine-Specific Multiplex Assay for Protein Biomarkers
Merck, a leading science and technology company, today announced the global launch of the first...
US FDA Expands IMBRUVICA (ibrutinib) Label to Include Overall Survival Data in Previously Untreated...
AbbVie a global biopharmaceutical company announced the U.S. Food and Drug Administration (FDA) updated the...